The regulatory mechanism of JNK signal transduction pathway-mediated multidrug-resistance in human hepatic cancer cell line Bel-7402/FU

Tumor

Volumn 34, Issue 1, 2014, Pages 19-25

  Huang, Can ^a   Xu, Du Juan ^a   Ju, Jing ^a   Xia, Quan ^a   Wang, Meng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Bel 7402 5 FU cells; JNK signal pathway; Liver neoplasms; Multidrug resistance associated proteins

Indexed keywords

EID: 84904501481     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2014.01.004     Document Type: Article

References (16)

1. HUANG C, XU D, XIA Q, et al. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II [J]. J Pharm Pharmacol, 2012, 64(12):1741-1750.
2. LIU S, WANG J, NIU W, et al. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer[J]. Cancer Lett, 2013, 328(2):325-334.
3. YANG S Y, MIAH A, SALES K M, et al. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment[J]. Int J Oncol, 2011, 38(6):1695-1702.
4. YANG Y I, LEE K T, PARK H J, et al. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through down-regulation of the Akt and NF-κB pathway[J]. Carcinogenesis, 2012, 33(12):2488-2498.
5. CHEN Y, ZHAO Y, WANG C, et al. Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells[J]. Med Sci Monit, 2012, 18(10):BR383-388.
6. SUI H, FAN ZZ, LI Q. Signal transduction pathways and transcriptional mechanisms of ABCB1/P-gp-mediated multiple drug resistance in human cancer cells[J]. J Int Med Res, 2012, 40(2):426-435.
7. GUL O, BASAGA H, KUTUK O. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures[J]. Brief Funct Genomic Proteomic, 2008, 7(1):27-34.
8. CHEN K G, SIKIC B I. Molecular pathways: regulation and therapeutic implications of multidrug resistance[J]. Clin Cancer Res, 2012, 18(7):1863-1869.
9. UMBRASAITE J, SCHWEIGHOFER A, KAZANAVICIUTE V, et al. MAPK phosphatase AP2C3 induces ectopic proliferation of epidermal cells leading to stomata development in arabidopsis[J]. PLoS One, 2010, 5(12):1-18.
10. MCCUBREY J A, STEELMAN L S, KEMPF C R, et al. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways[J]. J Cell Physiol, 2011, 226(11):2762-2781.
11. ZHOU J, LIU M, ANEJA R, et al. Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase[J]. Cancer Res, 2006, 66(1):445-452.
12. KAWASAKI K, WATANABE M, SAKAGUCHI M. REIC/DKK-3 over-expression down-regulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer[J]. Cancer Gene Ther, 2009, 16(1):65-72.
13. MANSOURI A, RIDGWAY L D, KORAPATI A L, et al. Sustained activation of JNK/p38MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells[J]. J Biol Chem, 2003, 278(21):19245-19256.
14. LIN J C, CHANG S Y, HSIEH D S, et al. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells[J]. J Urol, 2005, 174(5):2022-2026.